Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FCNAD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,075
Award facts
- Contract value 100% obligated
- $17,074.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On September 11, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $17,074.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued under contract 4569451451, is for the supply of EXPAREL 266 mg/20 ml vials, a local anesthetic medication used in surgical and medical settings. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, and carries no set-aside designation beyond the vendor's woman-owned small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA's SPE2DB program, a $499,999,999 vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. As a primary supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio of contract awards with the DLA covering prescription medications, biologics, over-the-counter products, and specialty pharmaceuticals. This positioning makes the company a critical distributor supporting military health system operations globally.
Quick answers
Who was awarded contract SPE2DB25FCNAD?
SPE2DB25FCNAD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FCNAD worth?
The government has obligated $17,075 on SPE2DB25FCNAD.
Is contract SPE2DB25FCNAD an order under another contract?
Yes. SPE2DB25FCNAD is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCNAD competed?
The extent of competition for SPE2DB25FCNAD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award